Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-77.4%Return on Equity
VS
Market
Sector
Industry
History
$ 2.21Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information
Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTSCAN THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TCRX - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 176.71M | $ -136.78M | -77.4% |
| 3/31/2025 | $ 210.2M | $ -131.48M | -62.55% |
| 12/31/2024 | $ 240.97M | $ -127.5M | -52.91% |
| 9/30/2024 | $ 229.09M | $ -111.3M | -48.59% |
| 6/30/2024 | $ 255.22M | $ -104.41M | -40.91% |
| 3/31/2024 | $ 122.97M | $ -96.8M | -78.72% |
| 12/31/2023 | $ 150.87M | $ -89.22M | -59.14% |
| 9/30/2023 | $ 168.96M | $ -88.33M | -52.28% |
| 6/30/2023 | $ 190.61M | $ -81.58M | -42.8% |
| 3/31/2023 | $ 78.02M | $ -72.63M | -93.09% |
Key Performance Insights, Last 5 Years
- TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, TSCAN THERAPEUTICS INC's average ROE has been -56.25%.
- The median ROE for TSCAN THERAPEUTICS INC during this period was -52.89%
- TSCAN THERAPEUTICS INC reached its highest ROE over the past 5 years at -30.24%.
- The lowest ROE recorded by TSCAN THERAPEUTICS INC in the same timeframe -93.09%
TSCAN THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for TSCAN THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -26.13M ] / Equity [ $ -42.46M ]
(=) ROE [ 0% ] TCRX - Return on Equity, Last 5 years
-93.09%
Minimum
Mar 31, 2023
-30.24%
Maximum
Dec 31, 2021
-56.25%
Average
-52.89%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |